Why do cgm only last 2 weeks

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: Continuous glucose monitors (CGMs) typically last 10-14 days due to sensor design limitations. The Dexcom G6 and G7 models are FDA-approved for 10-day wear, while Abbott's FreeStyle Libre 2 and 3 last 14 days. This duration balances accuracy with practical considerations like sensor drift and skin irritation. Manufacturers design sensors with finite enzyme activity and membrane permeability that degrade over time.

Key Facts

Dexcom G6 and G7 sensors are FDA-approved for 10-day wear
Abbott FreeStyle Libre sensors last 14 days per manufacturer specifications
Sensor accuracy typically declines after 10-14 days due to enzyme degradation
FDA requires 95% of readings within ±20% of reference values for days 1-10
Most insurance plans cover sensor replacements every 10-14 days

Overview

Continuous glucose monitors (CGMs) emerged in the late 1990s, with the first FDA-approved system (GlucoWatch) arriving in 2001. Modern CGMs like Dexcom's systems (first approved in 2006) and Abbott's FreeStyle Libre (FDA-approved in 2017) revolutionized diabetes management by providing real-time glucose readings. These devices use subcutaneous sensors that measure glucose in interstitial fluid rather than blood. The 10-14 day lifespan represents a compromise between clinical accuracy and patient convenience, as early systems required more frequent calibration. Current models like the Dexcom G7 (2022) and FreeStyle Libre 3 (2020) maintain accuracy standards while extending wear time from earlier 3-7 day systems. The global CGM market reached $5.3 billion in 2022, with over 1.5 million users in the U.S. alone.

How It Works

CGMs use electrochemical sensors containing glucose oxidase enzymes that react with interstitial glucose. A tiny filament (0.2-0.4 mm diameter) inserted under the skin contains this enzyme-coated electrode. When glucose molecules contact the enzyme, they produce hydrogen peroxide, generating electrical current proportional to glucose concentration. This signal transmits wirelessly to a receiver or smartphone. The 10-14 day limit occurs because the enzyme activity decreases over time, membrane permeability changes, and the body's foreign body response creates fibrous encapsulation. Sensor drift increases after approximately 10 days, with accuracy declining beyond ±20% error margins. Manufacturers program automatic expiration to prevent unreliable readings, as studies show mean absolute relative difference (MARD) values increase from 9-10% in days 1-10 to 12-15% by day 14.

Why It Matters

The 10-14 day lifespan impacts 38.4 million Americans with diabetes who rely on accurate glucose data. Proper sensor duration reduces hypoglycemia events by 40% and A1C levels by 0.5-1.0% compared to fingerstick testing. Insurance coverage typically aligns with manufacturer-recommended replacement schedules, affecting out-of-pocket costs. Extended wear could improve adherence, as studies show 25% of users experience skin irritation requiring rotation sites. Future developments aim for 30+ day sensors, potentially reducing annual costs from $3,000-6,000 per patient. Accurate CGM data enables automated insulin delivery systems, preventing dangerous glucose fluctuations that cause 200,000 annual emergency visits.